医学
前列腺癌
雄激素剥夺疗法
前列腺切除术
泌尿科
放射治疗
激素疗法
植入
前列腺特异性抗原
外科
内科学
癌症
出处
期刊:JAMA
[American Medical Association]
日期:1998-09-16
卷期号:280 (11): 969-969
被引量:4421
标识
DOI:10.1001/jama.280.11.969
摘要
Low-risk patients had estimates of 5-year PSA outcome after treatment with RP, RT, or implant with or without neoadjuvant androgen deprivation that were not statistically different, whereas intermediate- and high-risk patients treated with RP or RT did better then those treated by implant. Prospective randomized trials are needed to verify these findings.
科研通智能强力驱动
Strongly Powered by AbleSci AI